Compare ARK Genomic Revolution ETF (ARKG) vs Prudential PLC (PUK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Prudential PLC — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Prudential PLC trades at $28.23 (market cap $34.34B). The key difference: Prudential PLC pays a 1.89% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Prudential PLC nearer its low. Which is the better fit depends on your goals.
| ARKG | PUK | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $33.61 |
52-Week Low | $23.09 | $24.65 |
Market Cap | — | $34.34B |
Enterprise Value | — | $35.78B |
Dividend Yield | — | 1.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Prudential Financial (PUK) trades at $28.13, up 1.33% with a bullish technical signal. The stock shows strong fundamentals with a P/E of 9.16, net income margin of 14.52%, and recent earnings beats. Revenue grew to $16.21B in 2024, with net income reaching $2.29B. Analyst consensus is 50% buy, 37.5% hold, and 12.5% sell. Recent news highlights Q2 2026 earnings anticipation and strategic moves in India.
Outlook is positive with robust profitability and valuation appeal, but risks include Japan sales suspension and regulatory scrutiny. The stock offers growth potential from international expansion, supported by solid cash flow and equity performance. Investors should weigh near-term headwinds against long-term strategic positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
